Helius Medical Technologies Inc [NASDAQ: HSDT] price surged by 141.67 percent to reach at $10.71.
A sum of 19961984 shares traded at recent session while its average daily volume was at 398.16K shares. Helius Medical Technologies Inc shares reached a high of $24.49 and dropped to a low of $16.81 until finishing in the latest session at $18.27.
The one-year HSDT stock forecast points to a potential upside of 99.39. The average equity rating for HSDT stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Helius Medical Technologies Inc [HSDT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HSDT shares is $3000.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HSDT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Noble Capital Markets have made an estimate for Helius Medical Technologies Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 24, 2021.
The Price to Book ratio for the last quarter was 2.06, with the Price to Cash per share for the same quarter was set at 5.63.
HSDT Stock Performance Analysis:
Helius Medical Technologies Inc [HSDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 210.71. With this latest performance, HSDT shares gained by 203.49% in over the last four-week period, additionally sinking by -94.03% over the last 6 months – not to mention a drop of -96.37% in the past year of trading.
Insight into Helius Medical Technologies Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Helius Medical Technologies Inc [HSDT] shares currently have an operating margin of -4918.64% and a Gross Margin at -98.31%. Helius Medical Technologies Inc’s Net Margin is presently recorded at -7215.25%.
Helius Medical Technologies Inc (HSDT) Capital Structure & Debt Analysis
According to recent financial data for Helius Medical Technologies Inc. ( HSDT), the Return on Equity (ROE) stands at -344.28%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -254.32%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Helius Medical Technologies Inc’s Return on Invested Capital (ROIC) is -353.22%, showcasing its effectiveness in deploying capital for earnings.
Helius Medical Technologies Inc (HSDT) Efficiency & Liquidity Metrics
Based on Helius Medical Technologies Inc’s (HSDT) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Helius Medical Technologies Inc (HSDT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Helius Medical Technologies Inc. (HSDT) effectively leverages its workforce, generating an average of -$1013809.52 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.32% and a Quick Ratio of 3.69%, indicating strong ability to cover short-term liabilities.
HSDT Stock EPS
With the latest financial reports released by the company, Helius Medical Technologies Inc posted -769.5/share EPS, while the average EPS was predicted by analysts to be reported at -795/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 25.5. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HSDT.
Helius Medical Technologies Inc [HSDT] Institutonal Ownership Details
There are presently around $1.46%, or 1.47%% of HSDT stock, in the hands of institutional investors.
